Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania 16802, USA.
J Biol Chem. 2010 May 21;285(21):16387-402. doi: 10.1074/jbc.M109.092676. Epub 2010 Mar 29.
We have reconstituted human mitochondrial transcription in vitro on DNA oligonucleotide templates representing the light strand and heavy strand-1 promoters using protein components (RNA polymerase and transcription factors A and B2) isolated from Escherichia coli. We show that 1 eq of each transcription factor and polymerase relative to the promoter is required to assemble a functional initiation complex. The light strand promoter is at least 2-fold more efficient than the heavy strand-1 promoter, but this difference cannot be explained solely by the differences in the interaction of the transcription machinery with the different promoters. In both cases, the rate-limiting step for production of the first phosphodiester bond is open complex formation. Open complex formation requires both transcription factors; however, steps immediately thereafter only require transcription factor B2. The concentration of nucleotide required for production of the first dinucleotide product is substantially higher than that required for subsequent cycles of nucleotide addition. In vitro, promoter-specific differences in post-initiation control of transcription exist, as well as a second rate-limiting step that controls conversion of the transcription initiation complex into a transcription elongation complex. Rate-limiting steps of the biochemical pathways are often those that are targeted for regulation. Like the more complex multisubunit transcription systems, multiple steps may exist for control of transcription in human mitochondria. The tools and mechanistic framework presented here will facilitate not only the discovery of mechanisms regulating human mitochondrial transcription but also interrogation of the structure, function, and mechanism of the complexes that are regulated during human mitochondrial transcription.
我们已使用源自大肠杆菌的蛋白成分(RNA 聚合酶和转录因子 A 和 B2)在 DNA 寡核苷酸模板上体外重建人线粒体转录,该模板代表轻链和重链-1 启动子。我们表明,相对于启动子,每个转录因子和聚合酶的 1 eq 都需要组装功能启动复合物。轻链启动子的效率至少比重链-1 启动子高 2 倍,但这种差异不能仅通过转录机制与不同启动子的相互作用差异来解释。在这两种情况下,产生第一个磷酸二酯键的限速步骤是开放复合物的形成。开放复合物的形成需要两种转录因子;然而,此后的步骤仅需要转录因子 B2。产生第一个二核苷酸产物所需的核苷酸浓度远高于随后核苷酸添加循环所需的浓度。在体外,转录的启动后控制存在启动子特异性差异,以及控制转录起始复合物转化为转录延伸复合物的第二个限速步骤。生化途径的限速步骤通常是那些受调控的步骤。像更复杂的多亚基转录系统一样,人类线粒体转录的控制可能存在多个步骤。这里提出的工具和机制框架不仅将有助于发现调节人线粒体转录的机制,而且还将有助于研究在人线粒体转录过程中受到调节的复合物的结构、功能和机制。